News from cvrx, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 08, 2014, 15:00 ET

CVRx® anuncia los primeros implantes comerciales de éxito de fallo cardiaco Barostim en Europa

 CVRx, Inc., una compañía privada de dispositivos médicos, anunció hoy los primeros 10 pacientes con fallo cardiaco...

Oct 08, 2014, 13:04 ET

CVRx® verlautbarte erste erfolgreiche, kommerziell erhältliche Barostim-Implantate zur Behandlung von Herzinsuffizienz in Europa

 CVRx Inc., ein nicht börsennotiertes Medizintechnikunternehmen, verlautbarte heute die ersten zehn Herzinsuffizienz-Patienten an, die...

Oct 08, 2014, 13:01 ET

CVRx® annonce la première réussite de pose d'implants commerciaux Barostim de traitement de l'insuffisance cardiaque en Europe

 CVRx, Inc., société privée de dispositifs médicaux, a annoncé aujourd'hui que 10 premiers patients atteints...

Oct 07, 2014, 11:17 ET

CVRx® Announces First Successful Barostim Heart Failure Commercial Implants in Europe

 CVRx, Inc., a private medical device company, announced today the first 10 heart failure patients treated with the Barostim neo System™...

Sep 29, 2014, 16:00 ET

CVRx® ontvangt CE Keurmerk voor het Barostim neo System™ voor de behandeling van hartfalen

 CVRx, Inc., een bedrijf in privé-eigendom voor medische instrumenten kondigde vandaag aan dat zij van de National Standards Authority of...

Sep 29, 2014, 14:18 ET

CVRx® recibe la aprobación de la marca CE para el Barostim neo System™

- CVRx® recibe la aprobación de la marca CE para el Barostim neo System™ para el tratamiento del fallo...

Sep 29, 2014, 12:33 ET

CVRx® reçoit la marque d'homologation CE du Barostim neo System™ pour le traitement de l'insuffisance cardiaque

 CVRx, Inc., une société privée de dispositifs médicaux, a annoncé aujourd'hui avoir reçu la marque...

Sep 29, 2014, 03:00 ET

CVRx® Receives CE Mark Approval of the Barostim neo System™ for the Treatment of Heart Failure

 CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland...

Sep 29, 2014, 03:00 ET

CVRx® riceve l'approvazione per il marchio CE per Barostim neo System™ per il trattamento dell'insufficienza cardiaca

 CVRx, Inc., una società a capitale privato per dispositivi medicali, ha annunciato oggi di avere ricevuto l'approvazione per il marchio...

Sep 29, 2014, 03:00 ET

CVRx® erhält CE-Kennzeichnung für das Barostim neo System™ für die Behandlung von Herzinsuffizienz

 CVRx, Inc., ein privates medizintechnisches Unternehmen, gab heute bekannt, man habe von der National Standards Authority of Ireland (NSAI)...

Sep 22, 2014, 04:00 ET

CVRx® Secures $15 Million Growth Capital Facility from Silicon Valley Bank

 CVRx, Inc., a private medical device company, announced today it secured a $15 million growth capital debt facility from Silicon Valley Bank....

Jun 09, 2014, 06:00 ET

CVRx® Achieves Two Significant Milestones for its Heart Failure and Hypertension Businesses

 CVRx, Inc., a private medical device company, announced today it achieved two significant milestones in its heart failure and hypertension...

Jan 07, 2014, 06:00 ET

Barostim Therapy™ Projected to be Cost-Effective in Treating Resistant Hypertension

CVRx, Inc., a privately held medical device company, today announced findings from a health-economic analysis published in the Journal of...

Nov 05, 2013, 07:00 ET

CVRx® & DaVita Announce Strategic Partnership

CVRx, Inc., a private medical device company, and DaVita®, a division of DaVita HealthCare Partners Inc, have embarked on a strategic...

Oct 30, 2013, 07:00 ET

CVRx® Closes $12 Million Additional Financing

 CVRx, Inc., a privately held medical device company, has closed on an additional $12 million under its Series F financing.  This brings...

Jul 10, 2013, 18:00 ET

CVRx®, Inc. Closes $29.6 Million Financing

CVRx, Inc., a private medical device company, has completed a private equity financing totaling $29.6 million. CVRx plans to use the funding for...

Apr 29, 2013, 07:00 ET

CVRx® Launches HOPE4HF™ Clinical Trial Evaluating Barostim neo™ in Heart Failure Patients

 CVRx, Inc., a private medical device company, announced the first patient enrolled in the Barostim HOPE4HF clinical trial. The study is...

Apr 29, 2013, 07:00 ET

CVRx® Gains Full FDA Approval for Hypertension Study

CVRx, Inc., a private medical device company, received Food and Drug Administration (FDA) investigational device exemption (IDE) approval, allowing...

Jul 09, 2012, 08:50 ET

CVRx® Names Philippe Wanstok Chief Commercial Officer

 CVRx, Inc., a privately-held medical device company, has appointed Philippe Wanstok to the newly created position of Chief Commercial Officer,...